SAN FRANCISCO, Nov. 03, 2017 -- Hagens Berman Sobol Shapiro LLP alerts investors in Tesla, Inc. (NASDAQ:TSLA) to the securities class action pending in the U.S. District Court for the Northern District of California. The Lead Plaintiff deadline is December 11, 2017. If you purchased or otherwise acquired securities of TSLA between May 4, 2016 and November 1, 2017 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/TSLA
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
On October 6, 2017, the Wall Street Journal reported: “Unknown to analysts, investors and the hundreds of thousands of customers who signed up to buy it, as recently as early September major portions of the Model 3 were still being banged out by hand, away from the automated production line, according to people familiar with the matter.” This news drove the price of TSLA shares down $13.94, or nearly 4%, to close at $342.94 on October 9, 2017.
Then, on November 1, 2017, the WSJ reported (a) “Tesla said it would build 10% fewer Model S and X vehicles in the fourth quarter than the third quarter” and (b) “[t]he outlook is even worse for the Model 3 […] [i]t now expects to produce 5,000 a week by the first quarter of next year, another slippage in its timeline.” This news drove the price of TSLA shares down as much as $24.80, or nearly 8%, during intraday trading on November 2, 2017.
“We’re focused on Tesla’s apparent omissions concerning its struggle to build the Model 3 and investor damages resulting from the recent revelations,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding Tesla should consider their options to help in the investigation or take advantage of the SEC whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000


How Marco Pharma International Preserves German Homeopathic Traditions in America
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



